⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GOSS News
Gossamer Bio, Inc. Common Stock
Pomerantz LLP Issues Alert Regarding Shareholder Class Action Against Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS
GOSS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Gossamer Bio, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
GOSS
GOSS EQUITY ALERT: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026 Ready to Announce with Confidence?
newsfilecorp.com
GOSS
GLOB
Pomerantz LLP Informs Shareholders of Securities Class Action Against Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS
Pomerantz LLP Informs Shareholders of Securities Class Action Filing Against Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS
Pomerantz LLP Informs Shareholders of Class Action Filing Against Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS
Bragar Eagel & Squire, P.C. Reminds Gossamer Investors that a Class Action Lawsuit Has Been Filed Against Gossamer Bio, Inc. (NASDAQ:GOSS) and Encourages Investors with Large Losses to Contact the Firm
globenewswire.com
GOSS
DEADLINE ALERT for GOSS, NUAI, and MEDP: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
globenewswire.com
GOSS
NUAI
MEDP
Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure– Hagens Berman
globenewswire.com
GOSS
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
GOSS